Translate this page into:
Authors’ response
*For correspondence: dr.adityasomani@aiimsraipur.edu.in
-
Received: ,
Accepted: ,
How to cite this article: Malani M, Das S, Saha A, Kumar A, Singh S, Somani A. Authors’ response. Indian J Med Res. 2026;163:130. DOI: 10.25259/IJMR_413_2026.
We thank the author of the letter to Editor1 for diligently reading our article2. It is agreed that while it is important to assess adverse effects in a systematic manner, it is even more important to report them to the national authority concerned. This exercise could help in generating knowledge based on a large database. Findings from small studies conducted at any one center may not serve the desired purpose, i.e. improvement in patient safety. The findings of our study2 were reported to the Indian Pharmacopoeia Commission, which is the national coordination center for the Pharmacovigilance Program of India (PvPI). The study hospital, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India, is one of the adverse-drug reactions’ (ADR) monitoring centers under the PvPI.3,4 It is continually engaged in sensitizing the clinicians and other stakeholders about PvPI and the importance of accurate monitoring and reporting of ADRs.4,5
The given manuscript is an apt reminder to improve knowledge about and practices towards pharmacovigilance program (PVP).2 Without getting desired cooperation and active contribution from the practicing clinicians, the PVP shall not build desired database and serve its intended purpose.
Financial support and sponsorship
None.
Conflicts of Interest
None.
Use of Artificial Intelligence (AI)-Assisted Technology for manuscript preparation
The authors confirm that there was no use of AI-assisted technology for assisting in the writing of the manuscript and no images were manipulated using AI.
References
- The critical role of pharmacovigilance in monitoring drug-induced QT prolongation. Indian J Med Res.. 2026;163:129-30.
- [Google Scholar]
- QT interval prolongation in schizophrenia: A cross–sectional study from a tertiary care center in Raipur. Indian J Med Res.. 2025;161:744-7.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Indian Pharmacopoeia Commission. List of ADR monitoring centers under pharmacovigilance programme of India (PVPI). Available from: https://ipc.gov.in/PvPI/adr/ADR.pdf, accessed on January 28, 2026.
- Pharmacovigilance Program of India. Ministry of Health and Family Welfare, Government of India. National Pharmacovigilance Week-2024. 17th September to 23rd September. Theme: Building ADR reporting culture for patient safety day. Available from: https://www.aiimsraipur.edu.in/upload/events/Consolidated%20PDF%20of%20daily%20reports.pdf, accessed on January 28, 2026.
- Press Information Bureau, Ministry of Health and Family Welfare, Government of India. AIIMS Raipur marks world patient safety day with CME on safer care for newborns and children. Available from: https://www.pib.gov.in/PressReleasePage.aspx?PRID=2167938®=3&lang=2, accessed on January 28, 2026.